<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>2</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Is Aspirin Still the Cornerstone of Antiplatelet Therapy in Patients With Coronary Artery Disease? An Historical and Practical Narrative Review</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>94</FirstPage>
			<LastPage>101</LastPage>
			<ELocationID EIdType="pii">49556</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2017.24</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Carol</FirstName>
					<LastName>Gravinese</LastName>
<Affiliation>Division of Cardiology, A.O.U San Luigi Gonzaga, Orbassano, Torino, Italy</Affiliation>

</Author>
<Author>
					<FirstName>Matteo</FirstName>
					<LastName>Bianco</LastName>
<Affiliation>Division of Cardiology, A.O.U San Luigi Gonzaga, Orbassano, Torino, Italy</Affiliation>
<Identifier Source="ORCID">0000-0002-6751-6437</Identifier>

</Author>
<Author>
					<FirstName>Enrico</FirstName>
					<LastName>Cerrato</LastName>
<Affiliation>Interventional Cardiology Unit, Infermi Hospital, Rivoli and San Luigi Gonzaga University Hospital, Orbassano, Italy</Affiliation>
<Identifier Source="ORCID">0000-0002-1260-7534</Identifier>

</Author>
<Author>
					<FirstName>Paola</FirstName>
					<LastName>Destefanis</LastName>
<Affiliation>Division of Cardiology, A.O.U San Luigi Gonzaga, Orbassano, Torino, Italy</Affiliation>
<Identifier Source="ORCID">0000-0001-5060-9568</Identifier>

</Author>
<Author>
					<FirstName>Alessia</FirstName>
					<LastName>Luciano</LastName>
<Affiliation>Division of Cardiology, A.O.U San Luigi Gonzaga, Orbassano, Torino, Italy</Affiliation>

</Author>
<Author>
					<FirstName>Alessandro</FirstName>
					<LastName>Bernardi</LastName>
<Affiliation>Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy</Affiliation>
<Identifier Source="ORCID">0000-0002-0235-1336</Identifier>

</Author>
<Author>
					<FirstName>Simone</FirstName>
					<LastName>Bellucca</LastName>
<Affiliation>Division of Cardiology, A.O.U San Luigi Gonzaga, Orbassano, Torino, Italy</Affiliation>

</Author>
<Author>
					<FirstName>Ferdinando</FirstName>
					<LastName>Varbella</LastName>
<Affiliation>Interventional Cardiology Unit, Infermi Hospital, Rivoli and San Luigi Gonzaga University Hospital, Orbassano, Italy</Affiliation>

</Author>
<Author>
					<FirstName>Fiorenzo</FirstName>
					<LastName>Gaita</LastName>
<Affiliation>Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy</Affiliation>
<Identifier Source="ORCID">0000-0003-3178-6205</Identifier>

</Author>
<Author>
					<FirstName>Roberto</FirstName>
					<LastName>Pozzi</LastName>
<Affiliation>Division of Cardiology, A.O.U San Luigi Gonzaga, Orbassano, Torino, Italy</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2017</Year>
					<Month>05</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Aspirin is an irreversible and non-selective inhibitor of cyclo-oxygenase. It represents the cornerstone of antiplatelet therapy and is used in secondary prevention of cardiovascular disease. Disagreement over the optimal maintenance dosage still exists; in America and Europe the most used doses of aspirin are 81 mg and 100 mg daily, respectively. There is also debate on the formulation and route of administration of the loading dose. The latest studies advise chewable and non-enteric coated aspirin; intravenous administration represents an alternative for unconscious or shocked patients. Aspirin hypersensitivity is characterized by the onset of respiratory, mucocutaneous, and systemic symptoms. It is marginally considered, but its prevalence is significant. International cardiologic guidelines only report the possibility of desensitizing intolerant patients or, alternatively, administering one single antiplatelet agent. Desensitization can induce a temporary tolerance to the drug and consists of the administration of sequential and incremental doses of aspirin. Rapid desensitization protocols have proven to be safe and effective in the vast majority of cases, and they should be included in the management of these patients. New studies are being carried out comparing aspirin with other antiplatelet agents, and the results will be available shortly.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Coronary Artery Disease/Therapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Drug Therapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Combination Drug-Eluting Stents</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Platelet Aggregation Inhibitors/Administration and Dosage</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Platelet Aggregation Inhibitors/Adverse Effects</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Percutaneous Coronary Intervention</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_49556_55055df57e5c23d67dd957d1a4bd8b91.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>2</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Factors That Influence Nurses’ Work-Family Conflict, Job Satisfaction, and Intention to Leave in a Private Hospital in Turkey</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>102</FirstPage>
			<LastPage>108</LastPage>
			<ELocationID EIdType="pii">49633</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2017.25</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Dilek</FirstName>
					<LastName>Ekici</LastName>
<Affiliation>Nursing Department, Health Science Faculty, Gazi University, Ankara, Turkey</Affiliation>
<Identifier Source="ORCID">0000-0002-8401-4172</Identifier>

</Author>
<Author>
					<FirstName>Kamuran</FirstName>
					<LastName>Cerit</LastName>
<Affiliation>Nursing Department, Health Science Faculty, Süleyman Demirel University, Isparta, Turkey</Affiliation>
<Identifier Source="ORCID">0000-0002-1234-4025</Identifier>

</Author>
<Author>
					<FirstName>Tugba</FirstName>
					<LastName>Mert</LastName>
<Affiliation>TOBB ETU Hospital, Ankara, Turkey</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2017</Year>
					<Month>04</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Introduction:&lt;/strong&gt; Nurses who have difficulty balancing their family role and responsibilities because of intense work pressure tend to leave their current jobs to work in organizations which offer better working conditions, lower workloads, and more managerial support.&lt;br /&gt; &lt;strong&gt;Objective:&lt;/strong&gt; This study aimed to determine nurses’ work-family conflict (WFC), job satisfaction, and intention to leave the job in a private hospital.&lt;br /&gt; &lt;strong&gt;Methods:&lt;/strong&gt; This descriptive study is based on a methodological and causal research design. The population of the study included 98 nurses working in a private hospital. The research model is tested with structural equation modelling (SEM).&lt;br /&gt; &lt;strong&gt;Results:&lt;/strong&gt; Nurses working changing shifts reported statistically higher levels of work-to-family conflict and workload than those consistently working daytime shifts. Managerial support and workload explained 48% of WFC. Work structure alone explained 44% of job satisfaction. Job satisfaction and WFC explained 17% of the variance in intention to leave.&lt;br /&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; Nurses who have difficulty balancing their family roles and responsibilities because of intense work pressure tend to leave their current jobs to work in organizations which offer better working conditions, lower workload, and more managerial support. The work structure of nurses should be reorganized in order to enhance nurses’ job satisfaction.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Nurses</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Workload</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Family Conflict</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Job Satisfaction</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_49633_73e4a23ae4137875047fc4ba71ea8d29.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>2</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Effects of Different Doses of Fentanyl on the Sedation of Infants Under Mechanical Ventilation; A Randomized Clinical Trial</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>109</FirstPage>
			<LastPage>112</LastPage>
			<ELocationID EIdType="pii">51974</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2017.26</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Bita</FirstName>
					<LastName>Najafian</LastName>
<Affiliation>Department of Pediatrics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-4029-1979</Identifier>

</Author>
<Author>
					<FirstName>Hamed</FirstName>
					<LastName>Eyvazloo</LastName>
<Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University (IAUPS), Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad Hossein</FirstName>
					<LastName>Khosravi</LastName>

						<AffiliationInfo>
						<Affiliation>Student Research Committee (SRC), Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>International Otorhinolaryngology Research Association (IORA), Universal Scientific Education and Research Network (USERN), Tehran, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0003-0426-5092</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2017</Year>
					<Month>08</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background:&lt;/strong&gt; Respiratory distress syndrome (RDS) is a medical emergency in infants resulting from a lack of or deficiency in surfactant, and leads to pulmonary failure. Surfactant and mechanical ventilation are among the primary treatments for helping infants with respiration. Some sedative drugs, such as benzodiazepines and opioids, are used to reduce stress and restlessness in infants under mechanical ventilation.&lt;br /&gt; &lt;strong&gt;Objective:&lt;/strong&gt; This study aimed to evaluate the effect of 2 different dosages of Fentanyl on sedation of infants under mechanical ventilation.&lt;br /&gt; &lt;strong&gt;Methods:&lt;/strong&gt; In this randomized clinical trial, infants with RDS were assessed, and restless infants under mechanical ventilation were included in the trial. Infants were randomly allocated into 2 groups. Infants in group A underwent treatment with 0.5 μg/kg fentanyl, and those in group B received 1 μg/kg of fentanyl. Demographic information as well as data on the duration of mechanical ventilation, length of hospital stay, and need for re-intubation were recorded on a pre-designed checklist.&lt;br /&gt; &lt;strong&gt;Results:&lt;/strong&gt; Ultimately, 60 infants (46 male and 14 female) with a mean gestational age of 36.7±1.48 weeks in group A and 36.2±1.42 weeks in group B underwent analysis (P=0.087). Patients in group A were hospitalized for 10.36±3.59 days, and those in group B were hospitalized for 10±3.95 days (P=0.642). Mean duration of mechanical ventilation was 3.96±2.02 days in group A and 3.51±1.5 days in group B infants (P=0.459).&lt;br /&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; The findings of the present study suggest that both doses of fentanyl (0.5 μg/kg and 1 μg/kg) reduced all parameters of respiratory distress, such as heart rate and respiratory rate, with no significant difference between the 2 doses.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Fentanyl</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Infantile Respiratory Distress Syndrome</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Mechanical Ventilation</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_51974_e2e102b4cdb5e9f688eb7833e0a3c322.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>2</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Epidemiology of Hereditary Coagulation Bleeding Disorders: A 15-Year Experience From Southern Iran</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>113</FirstPage>
			<LastPage>117</LastPage>
			<ELocationID EIdType="pii">51384</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2017.27</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Azadeh</FirstName>
					<LastName>Farjami</LastName>
<Affiliation>Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Sezaneh</FirstName>
					<LastName>Haghpanah</LastName>
<Affiliation>Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-8666-2106</Identifier>

</Author>
<Author>
					<FirstName>Peyman</FirstName>
					<LastName>Arasteh</LastName>

						<AffiliationInfo>
						<Affiliation>Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of MPH, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-6499-9093</Identifier>

</Author>
<Author>
					<FirstName>Rezvan</FirstName>
					<LastName>Ardeshiri</LastName>
<Affiliation>Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hakimeh</FirstName>
					<LastName>Tavoosi</LastName>
<Affiliation>Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-6867-0495</Identifier>

</Author>
<Author>
					<FirstName>Zohre</FirstName>
					<LastName>Zahedi</LastName>
<Affiliation>Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Shirin</FirstName>
					<LastName>Parand</LastName>
<Affiliation>Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-5881-9807</Identifier>

</Author>
<Author>
					<FirstName>Mehran</FirstName>
					<LastName>Karimi</LastName>
<Affiliation>Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8555-1001</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2017</Year>
					<Month>09</Month>
					<Day>26</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background:&lt;/strong&gt; Data on the frequency of hereditary bleeding disorders (HBDs) and associated mortality and morbidities during a long-term follow-up from Iran are scarce.&lt;br /&gt; &lt;strong&gt;Objective:&lt;/strong&gt; This study evaluated the epidemiologic features among patients with HBD in one of the largest referral centers in southern Iran.&lt;br /&gt; &lt;strong&gt;Methods:&lt;/strong&gt; In this cross-sectional study, 619 patients with HBD were evaluated during the period 1996 to 2011. Aside from baseline characteristics and type of factor deficiency, associated morbidities including viral infections, neurological disorders, asthma, thalassemia, glucose-6-phosphate dehydrogenase (G6PD) deficiency, diabetes, hypertension, cardiac and renal diseases were evaluated. Furthermore, among patients who died, the underlying disease and etiology of death were also evaluated.&lt;br /&gt; &lt;strong&gt;Results:&lt;/strong&gt; Patients’ mean age was 24.4 ± 13.5 years. Factor VIII deficiency was the most prevalent type (50.4%) of HBD, and combined Von–Willebrand and factor XIII deficiency (2.3%) was the most prevalent type of combined factor deficiency. A total of 0.5% had hepatitis B and 11.5% had hepatitis C. Cardiac disease was seen in 1.5%, hypertension in 0.2%, renal disease in 0.2%, and diabetes in 1.3% of patients. Overall, 5.2% had intracranial hemorrhage, 2.1% had epilepsy, and 0.8% had mental retardation. During the 15-year follow-up, 22 patients died; car accident was the leading cause of death in this population.&lt;br /&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; Associated morbidities were seen in 24.3% of patients with HBD. Most prevalent morbidities were HCV infections (11.5%) and neurological disease (7.3%). The mortality rate among patients with HBD was 3.4%, and the most common cause of death was accident, which is similar to that of normal Iranian populations.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Hereditary Bleeding Disorder</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Morbidity</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">mortality</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hemophilia</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_51384_72ab967f8559ce300b06bf5d54789c00.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>2</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Effects of Different Times of Glutaraldehyde 2% on Bacillus subtilis Spores (In Vitro)</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>118</FirstPage>
			<LastPage>121</LastPage>
			<ELocationID EIdType="pii">53461</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2017.28</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Eshagh</FirstName>
					<LastName>Lasemi</LastName>
<Affiliation>Craniomaxillofacial Research Center, Tehran Dental Branch, Islamic Azad University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8927-8719</Identifier>

</Author>
<Author>
					<FirstName>Mohammad Hossain</FirstName>
					<LastName>Kalantar Motamedi</LastName>

						<AffiliationInfo>
						<Affiliation>Craniomaxillofacial Research Center, Tehran Dental Branch, Islamic Azad University, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Trauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Fina</FirstName>
					<LastName>Navi</LastName>
<Affiliation>Craniomaxillofacial Research Center, Tehran Dental Branch, Islamic Azad University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-7342-8193</Identifier>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Rezae</LastName>
<Affiliation>Department of Microbiology, Dental Branch, Islamic Azad University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Niousha</FirstName>
					<LastName>Homay Nikfar</LastName>
<Affiliation>Private Practice</Affiliation>

</Author>
<Author>
					<FirstName>Zahra</FirstName>
					<LastName>Danial</LastName>

						<AffiliationInfo>
						<Affiliation>Trauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Faculty of Psychology &amp; Educational Sciences, Allameh Tabataba’i University, Tehran, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-1409-8972</Identifier>

</Author>
<Author>
					<FirstName>Roojan</FirstName>
					<LastName>Azizpour</LastName>
<Affiliation>Craniomaxillofacial Research Center, Tehran Dental Branch, Islamic Azad University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-7588-2234</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2017</Year>
					<Month>02</Month>
					<Day>20</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background:&lt;/strong&gt; Due to the importance of disinfectant and sterilization of dental instruments, in total, 14%–28% of dentists, 13% of assistants, and 17% of healthcare workers (HCWs) have been subjected to the hepatitis B virus (HBV), and more than 200 healthcare providers (HCPs) pass away annually in the United States from HBV infection catched from their work place.&lt;br /&gt; &lt;strong&gt;Objective:&lt;/strong&gt; This study examined the effects of glutaraldehyde 2% on &lt;em&gt;Bacillus subtilis&lt;/em&gt; spores in the Surgery and Microbiology Department of the Dental Branch of Islamic Azad University.&lt;br /&gt; &lt;strong&gt;Methods:&lt;/strong&gt; This experimental research evaluated a total of 58 samples, one called first evidence (pure glutaraldehyde not exposed to spore suspension), one called second evidence (spore suspension not exposed to glutaraldehyde), and 40 samples including a suspension with a normal turbidity of 1×108 CFU/mL according to 0.5 McFarland with exposure to glutaraldehyde 2%. Experiments were done in time intervals of 10, 15, 20, 25, 30, 40, and 60 minutes with 8 repeats. In all times, a &lt;em&gt;B. subtilis&lt;/em&gt; spore suspension was used as evidence and also as a case.&lt;br /&gt; &lt;strong&gt;Results:&lt;/strong&gt; This research was done on 58 samples. The results showed that in the 10th minute there were 102 colonies, 18.6 ± 3.4 in the 15th minute, 6.2 ± 1.4 in the 20th minute, 2.1 ± 0.8 in the 25th minute, and no colonies after 30 minutes. In an overall observation, it was seen that there were more colonies in the first 10 minutes, and from 15 to 20 minutes, this amount significantly decreased; after 30 minutes in each 8 repeats, the growth of colonies had stopped completely, while in the evidence samples, &lt;em&gt;B. subtilis&lt;/em&gt; spores grew.&lt;br /&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; It seems that the density of 2% glutaraldehyde in 30 minutes time was enough to destroy the spores of &lt;em&gt;B. subtilis&lt;/em&gt;.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Glutaraldehyde</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Bacillus Subtilis Spores</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Disinfection</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_53461_4b084ae4ac122a74d6c6b960b9f32c14.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>2</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Creating a Better Patient Safety Culture in Taiwan: The Viewpoints of Physicians and Registered Nurses</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>122</FirstPage>
			<LastPage>124</LastPage>
			<ELocationID EIdType="pii">51214</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2017.29</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Chih-Hsuan</FirstName>
					<LastName>Huang</LastName>

						<AffiliationInfo>
						<Affiliation>School of Business Administration, Hubei University of Economics, Wuhan, China</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Institute for Development of Cross-Strait Small and Medium Enterprise, Hubei University of Economics, Wuhan, China</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-0955-6000</Identifier>

</Author>
<Author>
					<FirstName>Hsin-Hung</FirstName>
					<LastName>Wu</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Business Administration, National Changhua University of Education, Changhua, Taiwan</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of M-Commerce and Multimedia Applications, Asia University, Taichung, Taiwan</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-3702-276X</Identifier>

</Author>
<Author>
					<FirstName>Yii-Ching</FirstName>
					<LastName>Lee</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Health Business Administration, Hung Kuang University, Taichung, Taiwan</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Quality Management Center, Shanghai Changtai Medical Technology Co. Ltd., Shanghai, China</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>The School of Health Policy and Management, Chung Shan Medical University, Taichung, Taiwan</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Li</FirstName>
					<LastName>Li</LastName>
<Affiliation>School of Management, Wuhan Institute of Bioengineering, Wuhan, China</Affiliation>

</Author>
<Author>
					<FirstName>Cheng-Feng</FirstName>
					<LastName>Wu</LastName>

						<AffiliationInfo>
						<Affiliation>Institute for Development of Cross-Strait Small and Medium Enterprise, Hubei University of Economics, Wuhan, China</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>School of Logistics and Engineering Management, Hubei University of Economics, Wuhan, China</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-0222-6674</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2017</Year>
					<Month>08</Month>
					<Day>27</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background:&lt;/strong&gt; Patient safety culture in healthcare organizations has become an important issue globally for improving medical services. In 2016, Taiwan’s National Health Insurance (NHI) system covered 99.6% of Taiwan’s population. With the enhancement of medical quality, patients expect medical service providers to care more about safety and medical service. Understanding physicians and registered nurses’ attitudes toward patient safety is a critical issue for healthcare organizations wanting to improve the quality of the medical care they provide.&lt;br /&gt; &lt;strong&gt;Objective:&lt;/strong&gt; The purpose of this study was to discern physicians and registered nurses’ attitudes toward patient safety using Sexton and colleagues’ Safety Attitudes Questionnaire (SAQ) in order to develop strategies for improving the quality of medical services.&lt;br /&gt; &lt;strong&gt;Methods:&lt;/strong&gt; Pearson correlation analyses were conducted to demonstrate the relationships among six patient safety culture dimensions. Physicians and registered nurses were asked to complete the questionnaire in a case hospital in Taiwan in 2016.&lt;br /&gt; &lt;strong&gt;Results:&lt;/strong&gt; The results of Pearson correlation analyses demonstrated a strong and positive relationship between perceptions of management and working conditions. Additionally, teamwork climate was highly correlated to safety climate. The results also illustrated that teamwork climate and job satisfaction were significantly related.&lt;br /&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; The assessment of patient safety culture can provide a basis for hospital managers to monitor the quality of the medical care provided at their organizations. Hospital managers should put more efforts into the essentially important elements of patient safety culture, such as teamwork climate, safety climate, perceptions of management, and working conditions, so as to continuously improve the quality of medical care.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Safety Attitudes Questionnaire</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Patient Safety Culture</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Physicians and Registered Nurses</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Healthcare</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_51214_1dcc1e8fab24558892deb9d5030ee495.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>Hospital Practices and Research</JournalTitle>
				<Issn>2476-390X</Issn>
				<Volume>2</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Bilateral Facial Paralysis and Otitis Media as the First Presentations of Wegener’s Granulomatosis: A Case Report</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>125</FirstPage>
			<LastPage>127</LastPage>
			<ELocationID EIdType="pii">50892</ELocationID>
			
<ELocationID EIdType="doi">10.15171/hpr.2017.30</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Seyed Mohammad Javad</FirstName>
					<LastName>Hosseini</LastName>
<Affiliation>Biological-Molecular Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-9143-4565</Identifier>

</Author>
<Author>
					<FirstName>Jaleh</FirstName>
					<LastName>Yousefi</LastName>
<Affiliation>Department of Otorhinolaryngology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-7410-0886</Identifier>

</Author>
<Author>
					<FirstName>Habib</FirstName>
					<LastName>Yaribeygi</LastName>
<Affiliation>Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-1706-6212</Identifier>

</Author>
<Author>
					<FirstName>Gholam Hossein</FirstName>
					<LastName>Alishiri</LastName>
<Affiliation>Department of Rheumatology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-0545-8462</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2017</Year>
					<Month>09</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Introduction:&lt;/strong&gt; Cranial nerve palsy in Wegener’s granulomatosis is a curious incident, particularly if it occurs without kidney or lung involvement. In a review of medical articles, only 1 case of Wegener’s granulomatosis with bilateral facial nerve palsy was found.&lt;br /&gt; &lt;strong&gt;Case Presentation:&lt;/strong&gt; The patient was a 16-year-old female who presented with pain and hearing loss in both ears and reduced muscle tone in the right side of her face. After myringotomy and ventilation tube embedding in both ears, she gradually developed infectious otorrhea in both ears. Despite antibiotic and antifungal therapy for 2 weeks after surgery, the patient developed paresis in the left facial nerve and gag reflex disorder. Both magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) tests were normal, but the C-anti-neutrophil cytoplasmic antibody (CANCA) test result was about forty times higher than normal, and a sinus biopsy also verified Wegener’s granulomatosis. The patient was then treated with pulse corticosteroid and cyclophosphamide therapy. Her gag reflex healed and the ear secretions stopped, but the facial nerve palsy continued.&lt;br /&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; Although cranial nerve involvement in Wegener’s granulomatosis is an unusual incidence, it may occur in some cases. In the current case, otitis media and cranial nerve paresis without kidney or lung disorders were the only signs of disease onset; of course, computerized tomography (CT) scan revealed a right mandibular sinus disorder without any clinical signs. Another important point in this case is that other identified Wegener’s patients were in their fourth or fifth decade of life; thus, Wegener’s was the last choice for a diagnosis in the current case.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Otitis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Granulomatosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Wegener Syndrome</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Paresis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Facial Nerve</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jhpr.ir/article_50892_66c62b60b79f881c67d1ea2b38d3a23c.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
